American Society of Hematology Virtual Meeting 2020
The 62nd ASH Annual Meeting & Exposition will commence virtually this year. The December 5-8 event typically has over 30,000 attendees and was originally to be held in San Diego. The 2020 virtual format features product, scientific, and educational, programs.
Biojo Sciences is currently seeking clinical-stage hematology assets to add to our development portfolio. If you are interested in licensing, please Contact Us.
About ASH
The American Society of Hematology’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH has more than 18,000 members from 100 countries. https://www.hematology.org/
About Biojo Sciences
Biojo Sciences is a global biopharmaceutical company developing novel clinical-stage therapies that improve patient and family lives. With locations in Bethesda, Maryland and Seoul, South Korea, we in-license and develop promising clinical-stage drug assets.
